A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors-Reference-Cited by-同舟云学术

A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors

Published:2014-09-06 Issue:18 Volume:5 Page:8161-8172
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Blumenthal Gideon M.¹,Gills Joell J.²,Ballas Marc S.¹,Bernstein Wendy B.¹,Komiya Takefumi¹,Dechowdhury Roopa¹,Morrow Betsy¹,Root Hyejeong¹,Chun Guinevere¹,Helsabeck Cynthia¹,Steinberg Seth M.³,LoPiccolo Jaclyn¹,Kawabata Shigeru²,Gardner Erin R.¹,Figg William D.¹,Dennis Phillip A.²

Affiliation:

1. Medical Oncology Branch, National Cancer Institute, Bethesda, MD

2. Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA

3. Biostatistics and Data Management Section, National Cancer Institute, Bethesda, MD

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia;International Journal of Oncology;2023-10-02

2. Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models;Cancers;2023-08-02

3. Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2;Signal Transduction and Targeted Therapy;2023-04-24

4. Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins;Nature Communications;2022-10-24

5. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates;Cancers;2021-08-05